Post-Marketing Non-Acute Safety Study in Japan After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons at High Risk of Severe COVID-19
N/A
The goal of this study is to assess serious adverse events associated with ...
Status
Completed
Location
CMIC Co., Ltd
Start Date
2022-11-15
Trial ID
NCT05894590
Epigenetics of Muscle Insulin Resistance
N/A
The investigators are trying to understand the role of DNA (deoxyribonuclei...
Status
Completed
Location
University of Arizona
Start Date
2016-11
Trial ID
NCT03259984
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
PHASE3
The purpose of this study is to evaluate the immunogenicity, safety, and re...
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19
PHASE1
The primary goal for this study is to evaluate the safety and reactogenicit...
Status
Completed
Location
Synexus Clinical Research US Phoenix Southeast, Inc.